|
WO2006055184A2
(en)
|
2004-11-16 |
2006-05-26 |
Janssen Pharmaceutica N.V. |
Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms)
|
|
US7709516B2
(en)
*
|
2005-06-17 |
2010-05-04 |
Endorecherche, Inc. |
Helix 12 directed non-steroidal antiandrogens
|
|
CA2678577A1
(en)
*
|
2007-02-26 |
2008-09-04 |
Vitae Pharmaceuticals, Inc. |
Cyclic urea and carbamate inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
|
|
JP5470557B2
(ja)
*
|
2007-07-26 |
2014-04-16 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤の合成
|
|
AR069207A1
(es)
*
|
2007-11-07 |
2010-01-06 |
Vitae Pharmaceuticals Inc |
Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
|
|
US8440658B2
(en)
|
2007-12-11 |
2013-05-14 |
Vitae Pharmaceuticals, Inc. |
Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
|
|
TW200934490A
(en)
*
|
2008-01-07 |
2009-08-16 |
Vitae Pharmaceuticals Inc |
Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
|
|
WO2009094169A1
(en)
*
|
2008-01-24 |
2009-07-30 |
Vitae Pharmaceuticals, Inc. |
Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
CA2714532A1
(en)
*
|
2008-02-11 |
2009-08-20 |
Vitae Pharmaceuticals, Inc. |
1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
|
|
US8598160B2
(en)
*
|
2008-02-15 |
2013-12-03 |
Vitae Pharmaceuticals, Inc. |
Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
|
WO2009117109A1
(en)
*
|
2008-03-18 |
2009-09-24 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
|
|
EP2291370B1
(en)
|
2008-05-01 |
2013-11-27 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
JP5696037B2
(ja)
|
2008-05-01 |
2015-04-08 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状インヒビター
|
|
US8242111B2
(en)
*
|
2008-05-01 |
2012-08-14 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
|
|
RU2531272C2
(ru)
|
2008-05-01 |
2014-10-20 |
Вайтаи Фармасьютиклз, Инк. |
Циклические ингибиторы 11бета-гидроксистероид-дегидрогеназы 1
|
|
WO2010010157A2
(en)
|
2008-07-25 |
2010-01-28 |
Boehringer Ingelheim International Gmbh |
INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
|
|
NZ590495A
(en)
|
2008-07-25 |
2012-10-26 |
Vitae Pharmaceuticals Inc |
Dihydropyridin-phenyl-3-oxazinan-2-ones as inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
EP2323994A1
(en)
|
2008-07-25 |
2011-05-25 |
Boehringer Ingelheim International GmbH |
Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
|
|
GB2463514C
(en)
*
|
2008-09-11 |
2018-09-26 |
Galapagos Nv |
Imidazolidine compounds and uses therefor
|
|
JP5679997B2
(ja)
|
2009-02-04 |
2015-03-04 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状阻害剤
|
|
TW201039034A
(en)
*
|
2009-04-27 |
2010-11-01 |
Chunghwa Picture Tubes Ltd |
Pixel structure and the method of forming the same
|
|
GEP20156309B
(en)
*
|
2009-04-30 |
2015-07-10 |
Vitae Pharmaceuticals Inc |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
US8680093B2
(en)
|
2009-04-30 |
2014-03-25 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
US8927539B2
(en)
|
2009-06-11 |
2015-01-06 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
|
|
EP2448928B1
(en)
|
2009-07-01 |
2014-08-13 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
TW201124138A
(en)
*
|
2009-09-02 |
2011-07-16 |
Valletta Health B V |
Imidazole-4-carboxylic acid for use in treating a disease related to extracellular reactive oxygen species
|
|
WO2011056737A1
(en)
|
2009-11-05 |
2011-05-12 |
Boehringer Ingelheim International Gmbh |
Novel chiral phosphorus ligands
|
|
AU2011212813B2
(en)
|
2010-02-04 |
2014-10-23 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
|
HUE030072T2
(en)
|
2010-05-12 |
2017-04-28 |
Radius Health Inc |
Therapeutic prescriptions
|
|
EP2576570A1
(en)
|
2010-05-26 |
2013-04-10 |
Boehringer Ingelheim International GmbH |
2-oxo-1,2-dihydropyridin-4-ylboronic acid derivatives
|
|
WO2011159760A1
(en)
|
2010-06-16 |
2011-12-22 |
Vitae Pharmaceuticals, Inc. |
Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
|
|
WO2011161128A1
(en)
|
2010-06-25 |
2011-12-29 |
Boehringer Ingelheim International Gmbh |
Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
|
|
RU2434851C1
(ru)
*
|
2010-07-22 |
2011-11-27 |
Александр Васильевич Иващенко |
Циклические n, n'-диарилтиомочевины или n, n'-диарилмочевины - антагонисты андрогенных рецепторов, противораковое средство, способ получения и применения
|
|
US9133182B2
(en)
|
2010-09-28 |
2015-09-15 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
|
WO2012059416A1
(en)
|
2010-11-02 |
2012-05-10 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical combinations for the treatment of metabolic disorders
|
|
EP2788330A1
(en)
*
|
2011-12-05 |
2014-10-15 |
Novartis AG |
Cyclic urea derivatives as androgen receptor antagonists
|
|
MX389702B
(es)
|
2016-06-22 |
2025-03-20 |
Ellipses Pharma Ltd |
Compuestos para usarse en el tratamiento de cancer de mama que expresa el receptor de androgenos (ar+).
|
|
CA3099155A1
(en)
|
2018-05-14 |
2019-11-21 |
Nuvation Bio Inc. |
Anti-cancer nuclear hormone receptor-targeting compounds
|
|
CA3138197A1
(en)
|
2019-05-14 |
2020-11-19 |
Nuvation Bio Inc. |
Anti-cancer nuclear hormone receptor-targeting compounds
|
|
EP4058464A1
(en)
|
2019-11-13 |
2022-09-21 |
Nuvation Bio Inc. |
Anti-cancer nuclear hormone receptor-targeting compounds
|
|
MX2023011241A
(es)
|
2021-03-23 |
2023-10-03 |
Nuvation Bio Inc |
Compuestos dirigidos a receptores de hormonas nucleares contra el cancer.
|
|
JP2024516024A
(ja)
|
2021-05-03 |
2024-04-11 |
ニューベイション・バイオ・インコーポレイテッド |
抗がん核内ホルモン受容体標的化化合物
|